Novartis chart may soon 'complete a well-defined bullish reversal,' Cappelleri says
The Swiss drugmaker reported earnings a few days ago and, so far, has done a good job holding near its recent highs.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
